Navigation Links
iCardiac Doubles Quarterly Revenues and Garners Innovation Recognition
Date:12/12/2012

Rochester, NY (PRWEB) December 12, 2012

Today, iCardiac Technologies, Inc., a leading global provider of cardiac safety assessment services, announced that the company doubled its fiscal first quarter revenues for the period ending September 30th, 2012. The new customer growth reflects iCardiac’s innovation around improving the precision of key cardiac safety measurements. This same innovation was recently recognized by local government officials as part of their promotion of more innovation nationally. This recognition follows iCardiac’s honor of being listed on the Science Coalition 100 of the nation’s 100 great technology transfer success stories and also as one of the fastest growing companies in Rochester, NY as determined by the Democrat & Chronicle.

“These honors, both locally and nationally, reflect iCardiac’s robust growth, which is tied to our solid commitment to client satisfaction in cardiac safety analysis,” said Mikael Totterman, chief executive officer of iCardiac. “Our team is growing and our company is poised for continued growth in 2013.”

iCardiac Technologies now serves 7 of the world’s 10 largest pharmaceutical companies, as well as numerous medium and small biotech, pharmaceutical and medical device clients.

About iCardiac
iCardiac Technologies is a global cardiac safety company that has commercialized advanced research originating at leading academic institutions and pharmaceutical companies. Its reach is international, working with pharmaceutical and medical device clients all over the world to bring the best results to cardiac safety. For more information visit: http://www.icardiac.com/.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10199599.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
2. CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2012
3. PDL BioPharma Completes Regular Quarterly Dividend Payment
4. Cord Blood America Revenues Up 37 Percent to $5.67 Million in 2011
5. CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011
6. iLuv Earns International Acclaim for Excellence and Innovation in Product Design
7. Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
8. NineSigma Engages AtriCure in the Ohio Third Frontier Open Innovation Incentive Program
9. The Scientist Proudly Announces the Top 10 Innovations of 2012
10. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
11. CHTF 2012 Opens: Innovation Is A Key Theme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... ... LABS, Inc. (LABS) announced in December 2016 that two new Zika Virus ... (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific for IgM and IgG ZIKV antibodies. ... under an Investigational New Drug (IND) study protocol. , Now, as part of ...
(Date:4/26/2017)... Kong (PRWEB) , ... April 26, 2017 , ... ... hosted in EMEA and North America this May on ... May 16-18 , Donald H. Taylor, Chairman of the Learning and Performance Institute ...
(Date:4/26/2017)... April 26, 2017  Genisphere LLC, provider of ... signed a collaborative and sponsored research agreement with ... Muro . The overall goal of the partnership ... various 3DNA designs and formulations after in ... of the vasculature as well as inflammatory responses, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Franz ... Lisp (CL) development tools, and market leader for Semantic Graph Database ... now available within the most effective system for developing and deploying applications to ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):